Keys to making immunotherapy work against pancreatic cancer found in tumor microenvironment

This study, led by researchers at the Johns Hopkins Kimmel Cancer Center, is the latest from an ongoing platform trial formed in 2015 to study immunotherapy treatments before surgery (neoadjuvant) and after surgery (adjuvant) in patients with pancreatic cancer.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news